Company Encyclopedia
View More
name
SINOHEALTH HLDG
02361.HK
Sinohealth Holdings Limited provides healthcare solutions for sales and marketing needs of medical product manufacturer clients in Mainland China, the Netherland, England, Hong Kong, Singapore, and internationally. It engages in the research and development, and provision of data insight solutions, data-driven publications and events, and software as a service (SaaS) products; research and development, and operation of Smart Medical Cloud under the business line of SaaS products; management of marketing and promotion services of medicine; operation of SaaS products; provision of internet information and internet data center services; production and publication of videos; and foreign-related market research business. The company also offers precision marketing solutions; and consulting and marketing services. It serves various fields, such as pharmaceutical industry, retail pharmacies, and physical examination and hospitals.
47.23 B
02361.HKMarket value -Rank by Market Cap -/-

Financial Score

28/12/2025 Update
C
Health Care TechnologyIndustry
Industry Ranking5/7
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreA
    • ROE13.70%B
    • Profit Margin23.90%A
    • Gross Margin55.50%B
  • Growth ScoreD
    • Revenue YoY-4.40%D
    • Net Profit YoY-2.10%C
    • Total Assets YoY3.55%C
    • Net Assets YoY1.82%C
  • Cash ScoreC
    • Cash Flow Margin418.41%C
    • OCF YoY-4.40%D
  • Operating ScoreC
    • Turnover0.48C
  • Debt ScoreA
    • Gearing Ratio17.42%A

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    SINOHEALTH HLDG suggests changing its name to "SINOHEALTH Technology Holdings"

    SINOHEALTH HLDG announced a proposal to change the company's name, with the Chinese dual foreign name changed to "SINOHEALTH Technology Holdings Limited"

    AASTOCKS·
    HK
    02361
    -1.73%
    AASTOCKS·
    HK
    02361
    -1.73%

    SINOHEALTH HLDG released its interim results, with a net profit of 24.5 million yuan, a year-on-year decrease of 42.1%

    According to the Zhitong Finance APP, SINOHEALTH HLDG released its performance report for the six months ending June 30, 2025. During this period, the group achieved revenue of RMB 148 million, a year-on-year decrease of 7.3%; net profit of RMB 24.5 million, a year-on-year decrease of 42.1%; and basic earnings per share of RMB 0.06

    Zhitong·
    HK
    02361
    -1.73%
    Zhitong·
    HK
    02361
    -1.73%

    SINOHEALTH HLDG issued a profit warning, expecting a year-on-year decrease of approximately 36% to 46% in net profit attributable to the parent company for the first half of the year

    SINOHEALTH HLDG issued a profit warning, expecting that the net profit attributable to the parent company in the first half of 2025 will decrease by approximately 36% to 46% year-on-year, and revenue will decrease by approximately 5% to 10%. The reasons for the profit decline include strategic adjustments to the business structure, increased investment in AI research and development, reduced government subsidies, increased foreign exchange losses, and decreased interest income

    Zhitong·
    HK
    02361
    -1.73%
    Zhitong·
    HK
    02361
    -1.73%

    SINOHEALTH HLDG announced that its net profit for 2024 is approximately 112 million yuan, an increase of 10.8% year-on-year

    SINOHEALTH HLDG announced its 2024 performance, with revenue of approximately 404 million yuan, a year-on-year increase of 1.9%; net profit of approximately 112 million yuan, a year-on-year increase of 10.8%. Earnings per share are 26.97 cents. The company has improved resource utilization efficiency, product optimization, and operational costs through the application of AI large models, with gross profit margin increasing from 56.4% to 57.8%, and net profit margin increasing from 25.5% to 27.7%

    Zhitong·
    HK
    02361
    -1.73%
    Zhitong·
    HK
    02361
    -1.73%

    SINOHEALTH HLDG: SINOHEALTH Technology launches "Healthcare Full-Scenario Intelligent Body"

    SINOHEALTH HLDG announced that its wholly-owned subsidiary SINOHEALTH Technology has launched the "Healthcare Full-Scenario Intelligent Body," a solution that utilizes artificial intelligence technology to enhance the efficiency of the healthcare industry. The intelligent body covers five major scenarios: medical, pharmacy, commercial, health management, and research and development, aiming to improve diagnostic efficiency, optimize pharmacy operations, support pharmaceutical companies in responding to market changes, provide full lifecycle health management services, and accelerate new drug development. SINOHEALTH Technology has collaborated with multiple hospitals and pharmaceutical companies to promote the practical application of the intelligent body

    Zhitong·
    HK
    02361
    -1.73%
    Zhitong·
    HK
    02361
    -1.73%
    © 2025 Longbridge｜Disclaimer